基于适应证的处方面板对急诊科直接口服抗凝药出院处方的影响
内布拉斯加医学中心于2022年3月14日实施基于适应证的DOAC处方面板,旨在辅助药物选择、剂量和监测。本研究回顾性分析面板实施前后从急诊出院的新开DOAC处方成人患者各100例,结果显示不适当处方率从18%降至7%(P=0.020),需药师干预的比例从31%降至17%(P=0.020),30天内急诊返回率无差异。
要点
- 基于适应证的DOAC处方面板可降低急诊出院不适当处方率(18% vs 7%)。
- 面板实施后需药师干预的比例显著下降(31% vs 17%)。
- 30天内急诊返回率两组无差异。
核心结论
- 实施基于适应证的DOAC处方面板降低了急诊科不适当处方率,并减少了药师干预需求。
研究设计与样本
- 回顾性图表审查,纳入成人患者从急诊出院时新开DOAC处方,面板前组(2020年1月1日至2022年3月13日)和面板后组(2022年7月1日至2023年9月14日)各100例,共200例。
主要发现
- 主要结局不适当处方率面板前组为18%,面板后组为7%(P=0.020)。
- 需药师参与的比例面板前组为31%,面板后组为17%(P=0.020)。
- 30天内因任何原因返回急诊的比例两组无差异。
关键数值与推荐
- 不适当处方率:面板前18% vs 面板后7%(P=0.020)。
- 需药师干预比例:面板前31% vs 面板后17%(P=0.020)。
临床怎么用
- 在急诊出院开具DOAC时使用基于适应证的处方面板,可辅助选择药物、剂量和监测,减少不适当处方和药师干预需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Anticoagulants are one of the leading causes of adverse drug event-related emergency department (ED) visits and emergent hospitalizations, and high rates of inappropriate prescribing practices may be contributing. Nebraska Medicine implemented a direct oral anticoagulant (DOAC) indication-based prescribing panel on March 14, 2022. The goal of the panel is to assist with agent selection, dosing, and monitoring while ensuring indications and quantities are defaulted correctly. The purpose of this study was to assess the impact of an indication-based DOAC panel on appropriate prescribing in the ED. METHODS: This retrospective chart review included adult patients discharged from the ED with a new DOAC prescription before and after implementation of an indication-based prescribing panel from January 1, 2020, to March 13, 2022, and from July 1, 2022, to September 14, 2023, respectively. Data were analyzed using descriptive statistics, χ2 tests, and Student's t tests. RESULTS: A total of 200 patients were included in the final analysis, with 100 in each group. The primary outcome of inappropriate prescriptions occurred in 18% of patients in the pre-panel group and 7% of patients in the post-panel group (P = 0.020). The difference in the proportion of prescriptions requiring pharmacist involvement between the pre- and post-panel groups was statistically significant at 31% vs 17%, respectively (P = 0.020). There was no difference between the groups in the rate of return to the ED within 30 days for any indication. CONCLUSION: Implementation of an indication-based prescribing panel for DOACs led to a decrease in inappropriate prescribing of DOACs in the ED. Use of the panel decreased the need for pharmacist intervention and resources.
引用
- Meyer K, Reha C, Gomez L, et al. Assessing the effects of an indication-based panel for prescribing direct oral anticoagulants at discharge from the emergency department of an academic medical center. Am J Health Syst Pharm. 2026. PMID: 41631701. doi:10.1093/ajhp/zxag028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。